OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells
Hang Su, Nan Wang, Ryohichi Sugimura
Differentiation (2023) Vol. 130, pp. 51-57
Open Access | Times Cited: 8
Hang Su, Nan Wang, Ryohichi Sugimura
Differentiation (2023) Vol. 130, pp. 51-57
Open Access | Times Cited: 8
Showing 8 citing articles:
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 5
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 5
Potency assays and biomarkers for cell-based advanced therapy medicinal products
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
AI-Based solutions for current challenges in regenerative medicine
Pedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, et al.
European Journal of Pharmacology (2024), pp. 177067-177067
Closed Access | Times Cited: 3
Pedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, et al.
European Journal of Pharmacology (2024), pp. 177067-177067
Closed Access | Times Cited: 3
A pluripotent road to immunoengineering
Yun Chang, Qing Deng, Xiaoping Bao
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 8, pp. 541-542
Closed Access | Times Cited: 4
Yun Chang, Qing Deng, Xiaoping Bao
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 8, pp. 541-542
Closed Access | Times Cited: 4
Reprogramming Cell Identity: Past Lessons, Challenges, and Future Directions
José Silva
Cellular Reprogramming (2023) Vol. 25, Iss. 5, pp. 183-186
Closed Access | Times Cited: 2
José Silva
Cellular Reprogramming (2023) Vol. 25, Iss. 5, pp. 183-186
Closed Access | Times Cited: 2
Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
Jinhe Jiang, Rutong Ren, Yan-jie Cheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access
Jinhe Jiang, Rutong Ren, Yan-jie Cheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access
Size and Surface Properties of Functionalized Organosilica Particles Impact Cell–Particle Interactions Including Mitochondrial Activity
Junna Nakamura, Yasuo Shiohama, Daniel Röth, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 24, pp. 30980-30996
Closed Access
Junna Nakamura, Yasuo Shiohama, Daniel Röth, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 24, pp. 30980-30996
Closed Access
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
Wangshu Li, Jiuxiang Feng, Jianan Peng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Wangshu Li, Jiuxiang Feng, Jianan Peng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
